Human ABCA4 is a large single polypeptide of 2273 amino acids organized as two structurally related tandem-arranged halves.
1 Each half consists of three structural domains, where the first is a transmembrane domain (TMD) comprising six transmembrane α-helices (TMs), two single TMs are at positions 22–42 (TM1) and 1377–1397 (TM7), delineating the beginning of the two halves, respectively. The second hydrophobic region is formed by the other five TMs, that is, TM2-6 at positions 653–899 and TM8-12 at positions 1670–1964. The second domain is a lumen domain, containing a large exocytoplasmic domain (ECD), that is, ECD1 50–645 and ECD2 1442–1644 positioned between TM1 and TM2–6 and TM7 and TM8–12.
35 The third domain, located on the cyroplasmic side of disk membrane at positions 958–1176 and 1934–2147, respectively,
36 is a large soluble-protein region containing the nucleotide-binding domain (NBD), responsible for ATP hydrolysis. TMDs are homologous only with a small subfamily of ABC transporters, containing the drug-binding sites and forming the structural system for translocation.
12,35,36 ECDs do not show a significant sequence similarity to known proteins, except for other ABCA4 sequences from different species. They are glycosylated
37 and are probably involved in the interactions with other proteins.
36 NBDs are the only regions of ABC transporters that are structurally highly conserved.
12 Based on functional and mutagenesis studies, NBD1 is responsible for basal ATPase activity, whereas NBD2 produces the retinal-stimulated increase in activity.
38,39 Suggested mechanism of transport proposed is based on the alternating access model, established for smaller ABC transporters.
40 Furthermore, the observation that ABCA4 translocates the substrate from the luminal to the cytoplasmic side of the rod outer segment (ROS) disk allowed us to consider ABCA4 an importer, which makes this protein unique among known eukaryotic ABC transporters.
41 In importers, the alternating access model suggests a high-affinity binding site located across the membrane from NBDs. NBD binding probably increases ATP affinity, favoring their interaction and a conformational transition within the TMDs leading to closure of the high-affinity substrate binding site and translocation of the substrate to the low-affinity site located on the cytoplasmic side of the membrane.
42